Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy
Clinical trial NCT07309185 · RECRUITING
Trial details
- NCT number
- NCT07309185
- Sponsor
- Shandong Tumor Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-24
- Primary completion
- 2027-07-31
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.